Introduction

Description of the condition
Osteoarthritis (OA) is a structural and functional failure of whole joint [1] and damage to joint cartilage, deterioration of the bone beneath the joint, swelling of the joint with newly formed bone, and mild inflammation of the synovial membrane [2] . Above all, OA is often associated with significant disability and reduction in quality of life [3] . This affects such as the knees, hips, fingers and lower spine. Researchers have reported that the knee joint is affected especially frequently, and the incidence of knee OA is increasing [4] . Unfortunately, the available treatments for OA are not perfect. Therefore, many studies, both pharmacological and non-pharmacological, focus on reducing pain and limitations to patient's daily functioning [5] . Email address: drmslee@gmail.com, mslee@kiom.re.kr (M.S. Lee) 1 These authors have contributed equally.
Description of the intervention
Acupuncture and moxibustion have been used as medical treatments in East Asia, including China, Korea and Japan [6] . Moxibustion have various techniques. There are two types of moxibustion: be divided into direct moxibustion and indirect moxibustion. When performing direct moxibustion, moxa sticks are burnt at acupoints directly on the skin. In contrast, in indirect moxibustion, the moxa cone does not touch the skin and is burnt while being insulated from the skin by some substance [7] . Warm needle acupuncture (WA) is the combination of acupuncture with moxibustion by stimulating acupoints with a burning moxa (also called Ai Ye) stick on the handle of the acupuncture needle [8] . The use of WA was first documented in Shang Han Za Bing Lun ("Discussion of Cold-Induced Disorders"), a classical Chinese medical book by Zhongjing Zhang (Eastern Han dynasty, 25-220 C.E.) [9] . WA is often used to treat painful conditions such as arthritis, especially rheumatoid arthritis and OA [10, 11] as well as musculoskeletal pain conditions [12, 13] . WA treatment is transmitted to the acupoint by radiation, moreover, by direction conduction through the shaft of the needle, thereby stimu lating deep tissue within the acupoint and warming the acupoint on the surface [14] .
How the intervention might work
WA for OA is widely used for treatment and prevention [15, 16] . Studies on the treatment of WA on OA have also shown a greater pain relief compared to manual acupuncture [17] . Furthermore, WA has reduced joint fluid and abnormally high serum levels of interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α), two inflammatory factors in patients with knee OA [18] .
Why it is important to do this review
Many studies have been reported treatment using WA treatment for OA in clinical practice [19, 20] . One recent review assessed the efficacy of WA for OA but the most of included studies suffered from high risk of bias [21] . The previous review focused on the WA treatment for knee OA and searched Chinses databases only. Furthermore, the review is outdated. Therefore, the aim of this systematic review was to update, complete and critically evaluate the evidence from randomized clinical trials (RCTs) of WA for OA.
Methods
Study registration
This protocol review has been registered on PROSPERO 2015 (registration number CRD42015024413) [22] .
Criteria for considering studies for this review
Types of studies
This systematic review will only include RCTs and quasi-RCTs. Observational, cohort, case reports, case series, non-RCT, animal and experimental studies will be excluded. No language restrictions will be imposed.
Types of participants
Patients suffering from OA will be included regardless of joint location (e.g., chronic condition of the neck, near the ends of the fingers, at the base of the thumb, back, hip, and knee). We will also include patients with both sexes and any age. Included patients will have been diagnosed with OA according to the American College of Rheumatology (ACR) criteria [23] [24] [25] , the equivalent European League Against Rheumatism (EULAR) criteria [26] [27] [28] , or the Clinical Guideline of New Drugs for Traditional Chinese Medicine [29] . Studies will be excluded if they include patients with rheumatoid arthritis, ankylosing arthritis, joint tuberculosis, purulent arthritis, allergic arthritis, Kashin-Beck disease or Podagra.
Types of interventions and controls
Studies that evaluate WA as the sole intervention will be included. Warm needle will be defined as moxa being attached to the needle once it is inserted. Traditionally, traditional medicine practitioners usually attach burning moxa to the handle of the AT needle to improve the effectiveness of the therapy. Electro-warmed needles and infrared radiation will be excluded. The combined intervention include western medicine or rehabilitation or physiotherapy, but exclude alternative therapy such as herbal medicine, chuna, acupuncture. A combined intervention will include western medicine or rehabilitation or physiotherapy, but will exclude any that combines other alternative therapies such as herbal medicine, Tuina, or other types of acupuncture.
Type of outcome measures
• Primary outcomes 
Searches of other resources
The authors will scan the reference lists and retrieve additional studies. In addition, authors will search the WHO International Clinical Trials Registry Platform (ICTRP) (http://apps.who.int/trialsearch/ ) and Google Scholar (http://scholar.google.co.kr/). Dissertations of degree will be included. The ClinicalTrials.gov registry (http:// clinicaltrials.gov/) will be searched for any unpublished trials.
Search strategy
The strategy for searching MEDLINE is described in Appendix A. The strategy for searching CNKI is described in Appendix B. Similar search strategies will be applied to other databases.
Data collection, extraction and assessment
Selection of studies
Two reviewers (JHJ and TYC) will independently screen the titles and abstracts for searched studies, and perform study selection and record their decisions according to predefined criteria. Another reviewers (MSL) will resolve disagreements of section study. Study selection will be documented and summarised in Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) flow diagram [33] .
Data extraction
Two reviewers (JHJ and TYC) will read studies and independently extract the data using a standard data extraction form. The form will be comprised of type of OA, participants, intervention group treatment, control group treatment, outcome and result. Disagreements of section study will be resolved by another reviewers (MSL). We will use Grading of Recommendations Assessment, Development and Evaluation (GRADE) software to judge the quality of evidence for data from Cochrane Systematic Reviews to create a Summary of Findings table [34] . Additionally, the details of the treatment regimens will be summarised in a table. When reported data are insufficient or unclear, an author will contact the first author or corresponding authors by e-mail or telephone to request missing or clarification data.
Accessement of risk of bias
To assess the quality of included studies according to the criteria described in the Cochrane Handbook for Systematic Reviews of Intervention [35] . The following items will be assessed: 1) random sequence generation; 2) allocation concealment; 3) blinding of participants and personnel; 4) blinding of outcome assessment; 5) completeness of outcome data; 6) completeness of reporting; 7) other sources of bias. Each trial will be categorized as having a low (L), unclear (U), or high (H) risk of bias. If necessary, we will contact the authors of assessed trials for clarification. We will resolve any differences in opinion through discussion or consultation with all of the authors.
Data synthesis
All statistical analyses will be performed using the Review Manager (Cochrane Collaboration Software, RevMan) version 5.3. For dichotomous data, we will present the treatment effects and use the risk ratios (RR) with 95% confidence intervals (CIs). For the continuous data, we will use the mean differences (MD) with 95% CIs. If outcome variables are measured on different scales, we will use a standard mean differences (SMD) analysis with 95% CIs.
Unit of analysis issues
The systematic review will include data from parallel-group studies for the meta-analysis. For cross-over trials, the first treatment period of data will be analyzed. In that case if there is more than one control group, each group will constitute a separate unit of analysis. If there are multiple treatment time observations, the data will be analysed as either short term (within 30days) or long term (over 30-days) . In addition, analysis will be divided into various types of OA.
Assessment of heterogeneity
We will use fix model if there is no evidence of heterogeneity; if not we will apply random effect model. If a meta-analysis is possible, we will use the I 2 statistic for quantifying inconsistencies across the included studies. A result 50% cut off point would represent substantial heterogeneity. If heterogeneity is observed, we will conduct subgroup analyses [36] .
Subgroup analysis and the investigation of heterogeneity
If studies and data are sufficient, subgroup analyses will be conducted according to: 1) Type of OA (e.g, knees, hip, back or fingers) 2) Type of control intervention (e.g, western medicine, no treatment or usual care)
Sensitivity analysis
We will use sensitivity analyses to investigate suspected funnel plot asymmetry. Sensitivity analysis will be conducted according to the following criteria:
1.) Methodological qualities (sequence generation, allocation concealment, or blinding in the assessment of outcomes and symptom severity) 2.) Sample size (more or less than 40 participants in each group)
In the analysis, we will exclude high risk of bias studies and compare the results with those using the worst-case scenario to combine studies. Then we will have a discussion to decide whether the high risk of bias studies should be excluded on the bias of sample size, strength of evidence and influence on pooled effect size.
Assessment of reporting biases
If more than 10 studies are available, we will conduct funnel plot for publication bias and small study effects using Egger's method. Funnel plot asymmetry is certainly not same as publication bias. We will attempt to distinguish the possible reasons for the asymmetry, therefore, included poor methodological quality and true heterogeneity of studies [37] .
Discussion
This protocol for a systematic review will provide a detailed summary of the current state of evidence regarding the effectiveness of the WA in treating the symptoms of patients with OA. The review will be useful to patients and healthcare providers in determining the appropriate role of WA in the treatment of OA.
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